A new human myeloid cell line has been established recently from the bone marrow cells of a patient with chronic myelogenous leukemia in blast crisis. The active proliferation and survival of the cells in RPMI 1640 medium containing fetal calf serum are clearly dependent on the presence of either natural or recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Despite permanent culturing in rhGM-CSF (100 U/mL), the cells do not differentiate and bear the myelomonocytic surface markers CD34, CD13, CD36, as well as HLA-DR, ELL LINES requiring specific factors for their survival, C proliferation, or growth inhibition are excellent biologic tools for studying the actions of factors in question. Various cell lines have been reported from mouse or human origins for interleukin-2 (IL-2),' tumor necrosis factor a (TNFa),' IL-6,' granulocyte colony-stimulating factor (G-CSF): and granulocyte-macrophage C S F (GM-CSF).5s6 GM-CSF is one of the well-characterized hematopoietic growth factors that acts on myeloid progenitor cells at various maturation stages and induces proliferation, differentiation, and functional stimulation.'-'* The proliferative effect of GM-CSF is not absolutely restricted to myeloid cells, since lymphatic leukemia cell lines: colon adenocarcinoma cell lines,13 and human endothelial cells14 also have been reported to respond to GM-CSF.
The disease had been diagnosed there primarily on the basis of clinical features of disease: white blood cell (WBC) count 228,000 (with 9% blasts, 3% promyelocytes, 18% myelocytes, 9% metamyelocytes, 19% band, 30% neutrophils, 6% eosinophils, 4% basophils, 2% lymphocytes); strongly decreased alkaline leukocyte phosphatase (3 score); as well as cytologic and histologic examination of the bone marrow specimen obtained through iliac crest puncture. Although an HLA typing had been performed, no karyotype analysis had been undertaken with respect to the Ph' chromosome.
Initially, the patient had been treated with busulfan orally until May 1987; but busulfan was ineffective, and was discontinued and replaced by hydroxyurea. The patient's family doctor then took over attendance in June 1987, but again had to refer her to the hospital in December 1988 because of a blast increase in peripheral blood. Two days later, she was sent to our clinic.
On examination, the patient appeared acutely ill and somnolent, with temperatures greater than 4OoC, dyspnea, and tachycardia. WBC count was 164,000 with 76% blasts, 16% neutrophils, 5% lymphocytes, and 3% monocytes, and the platelet count was 46,000. Phenotype examination of the peripheral blood leukocytes gave clear evidence that the blast cells bore myeloid antigens such as 5% CD3 CD13 (My7), and 20% CD33 (My9). Cytochemical staining of bone marrow cells showed that 25% of the blasts were positive for esterase but were negative for peroxidase and PAS.
Despite treatment with antibiotics, the patient finally died of an overt pneumonia and sepsis on the third hospital day.
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MATERIALS AND METHODS

Bone marrow cells.
With the patient's prior informed consent, marrow cells were obtained by means of iliac crest puncture. Mononuclear cells were separated by density-gradient centrifugation on Ficoll (Nycomed AS, Oslo, Norway) and cultured in RPMI 1640 medium with 10% fetal calf serum (FCS) and growth factors. Part of the cells were preserved by freezing in liquid nitrogen with 10% dimethylsulfoxide (DMSO) and RPMI 1640 medium containing 40% FCS, and these were used later for karyotype analysis. 
RESULTS
Establishment and cellular characteristfcs. Initially. bone marrow mononuclear cells were cultured in the presenceof rhG-CSF. rhGM-CSF. and IL-3 (1.OOO U/mLcach) with the intention of studying the differentiation capacity of the blast cells. As usual, the culture medium used was RPMl 1640, supplemented with 10% FCS. 0.2 mmol/L Lglutamine, and antibiotics. Within the first 2 weeks there were no differences to be detected. either in proliferation rate or in maturation of the cells in the presence of these three hematopoietic growth factors. However, after scveral passages an active proliferation was sustained only by the cells exposod to rhGM-CSF. In subsequent steps. three stable subclones were established by using limiting dilution tech- nique. These subclones differ in their morphology and generation time, but they still retain their requirement for external supply of rhGM-CSF. The dependency can be circumvented if the cells are cultured by carefully reducing GM-CSF for 2 or more weeks. As a consequence, cells that have once become independent do not require GM-CSF for their survival and proliferation, whereas they sustain to respond to GM-CSF with increased proliferation (data not shown). To avoid overly complex data, only the clone termed as GM/SO is discussed in this report.
Although there is a considerable variation in cell size, the typical morphology of GM/SO cells in May-Grunwald staining is a large, round, or slightly irregular nucleus, three to six prominent nucleoli, and deep blue cytoplasm with a perinuclear pale zone (Fig 1A) . There is no granula present and the cytochemical staining for PAS, myeloperoxidase, and cy-naphtyl acetate esterase are negative. Moreover, the cells growing in 100 U/mL rhGM-CSF (unless otherwise stimulated) retain their morphology and display no overt differentiation in liquid culture. However, a rapid change 
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into a monocyte-macrophage morphology and increased adherence to plastic surface can be induced by the addition of phorbol myristatc acetate (PMA) (Sigma. St Louis. MO) at concentrations between 1 . 0 0 ng/ml. and I ng/ml. (Fig   I R) .
lmmunophenotype analysis showed that the GM/SO cells clearly bear surface antigens of myelomonocytic cells CD34 (greater than 75%). CDI3 (greater than 968). and CD36 (greater than 92%). but not the other typical granulocytemacrophage antigens such as CDllb. CD14. or CD16.
While HLA-DR (grater than 98%) i s strongly expressed on the cells. lymphocytic markers such as CD3. CD7. CDIO. CD2O. and thrombocytic marker CD42b are also definitely absent.
As shown in Fig 2. the proliferative effect of GM-CSF on these cells is dose-dependent. and the saturating dosis seems to be by I 0 0 U/mL. However. by using a poljvalent rabbit antiserum against GM-CSF at neutraliting titers, the proliferation could be completely abolished in these assays. This inhibition apparently is not due to any toxic effect in antiserum. since the neutralizing effect could in turn be entirely suppressed by e x c e~~ of rhGM-CSF in culture medium. In addition, we simultaneously tested rhG-CSF and rhlL-3. as well as rhlL-In. rhlL-2. rhlL-4. and rhlL-6 to rule out any pssible effect on this cell line. As the given examples demonstrate. there was no detectable proliferative effect of these cytokines at concentrations between I and 1.000 U/mL. either alone or in combination with I U/mL rhG M-CSF. (Fig 3) . Since various numerical chromosomal anomalies were observed in the bone marrow blast cells. at least one of these markers (MI ). together with the 9q c chromosome.
seems to be characteristic for the patient's leukemic transformation because it was also present in all metaphases of the bone marrow cells freshly frozen during the blast crisis. In the course of establishment. an increasing rate of tetraploid karyotypes was found in subsequent analyses. Southern blot analysis of &/I1 digested DlUA with bcr-5' as hybridiiation probe showed two &/lI restriction fragments of 8. 6 and I 1 .O kilobase pair (kbp) s i x . givingclear evidence for a rearrangement typical for CML (Fig 4. lane A) . Additionally. the signal of the 8.6 kbp fragment. i f compared to the 5.0 kbp. is many times stronger. and in this case indicates an amplification proms. The Occurrence of two aberrant fragments was observed in several blotting and hybridiistion experiments: thus. an artifact due to partial digestions i s excluded.
Cytogenetic and DNA a d y s i s .
DISCUSSION
The cell lines that were established in recent dccades have become an essential part of our contemporary biomedical research. Their contributions to discovering various new diagnostic and therapeutic agents can actually be exemplified with the development of MoAbs." purification of cytokines?" bioassays.'.'.m and so forth. In this context. the factor-dependent cell lines. being an ideal subject for studying the physiologic relevance of the factor in question. are undoubtedly of particular interest. In this report we describe a new human myeloid cell line GM/SO. of which survival and proliferation in vitro is primarily dependent on the presence of hGM-CSF. either natural or recombinant. Apart from excluding probable effec~s of rhlL-la. rhlL-2. rhlL-3. rhlL-4, rhlL-6. and rhG-CSF on GM/SO by testing them directly. we provided evidence by using a neutralizing antibody that the factor responsible for the detected proliferation is restricted to GM-CSF. In contrast to the reported synergistic effect of rhG-CSF." IL-6.:' and IL-3:' on leukemic blasts or normal CD34+ cells. respectively. we failed to observe such a synergism on GM/SO cells. rhM-CSFand IL- 5 have not yet k e n assayed.
In addition. we confirmed through immunophenotyping In summary, the data presented herein suggest that the GM/SO cell line possesses a functionally intact receptor for hGM-CSF as well as some characteristics of its normal counterpart. Apart from the use for bioassay, it is likely that prospective studies on this cell line may contribute to the understanding of the physiologic consequence of the interaction between GM-CSF and myelogenous cells.
